{
    "clinical_study": {
        "@rank": "46982", 
        "arm_group": [
            {
                "arm_group_label": "N-hydroxy-nor-arginine", 
                "arm_group_type": "Experimental", 
                "description": "N-hydroxy-nor-arginine 0.1 mg/ min i.a. for 20 min"
            }, 
            {
                "arm_group_label": "NaCl", 
                "arm_group_type": "Placebo Comparator", 
                "description": "NaCl 0.9%, 6 ml/min i.a. for 20 min"
            }
        ], 
        "brief_summary": {
            "textblock": "The present project is designed to test the hypothesis that arginase contributes to\n      endothelial dysfunction induced by ischemia-reperfusion in patients with coronary artery\n      disease."
        }, 
        "brief_title": "Arginase Inhibition in Ischemia-reperfusion Injury", 
        "condition": [
            "Coronary Artery Disease", 
            "Type 2 Diabetes Mellitus"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Ischemia", 
                "Reperfusion Injury"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Coronary artery disease\n\n        Exclusion Criteria:\n\n          -  Age >80 years, Myocardial infarction/unstable angina within 6 weeks prior to the\n             study, Raynaud's phenomenon, peripheral vasculopathies, arterial shunting or other\n             vascular surgery of the study arm, Any concomitant disease or condition that may\n             interfere with the possibility for the patient to comply with or complete the study\n             protocol, Participant in an ongoing study, Unwillingness to participate following\n             oral and written information."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009527", 
            "org_study_id": "AIR"
        }, 
        "intervention": [
            {
                "arm_group_label": "N-hydroxy-nor-arginine", 
                "intervention_name": "N-hydroxy-nor-arginine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "NaCl", 
                "intervention_name": "NaCl", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 9, 2013", 
        "location": {
            "contact": {
                "email": "john.pernow@ki.se", 
                "last_name": "John Pernow, Professor", 
                "phone": "+46851775876"
            }, 
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "17176"
                }, 
                "name": "Karolinska Institutet"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Arginase Inhibition on Endothelial Function Induced by Ischemia-reperfusion in Patients With Coronary Artery Disease", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Flow-mediated dilatation of the radial artery", 
            "measure": "Change in endothelial function", 
            "safety_issue": "No", 
            "time_frame": "20 min of reperfusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009527"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska Institutet", 
            "investigator_full_name": "John Pernow", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Karolinska Institutet", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Karolinska Institutet", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}